(Q44193624)

30 November 2017

Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro (English)

1 reference

30 November 2017

0 references

0 references

Kenjiro Ono

1

1 reference

30 November 2017

Kazuhiro Hasegawa

series ordinal

2

1 reference

30 November 2017

Masahito Yamada

series ordinal

3

1 reference

30 November 2017

Hironobu Naiki

series ordinal

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

Biological Psychiatry

1 reference

30 November 2017

52

1 reference

30 November 2017

9

1 reference

30 November 2017

880-886

1 reference

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Prospects for pharmacological intervention in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Anti-amyloidogenic activity of tetracyclines: studies in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Interaction between A beta(1-42) and A beta(1-40) in Alzheimer's beta-amyloid fibril formation in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Beneficial effects of nicotine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Smoking and oestrogen-replacement therapy as protective factors for Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Nicotinic acetylcholine involvement in cognitive function in animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

In vitro and in vivo studies investigating possible antioxidant actions of nicotine: relevance to Parkinson's and Alzheimer's diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Kinetic theory of fibrillogenesis of amyloid beta-protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Kinetic analysis of amyloid fibril formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer's beta-amyloid fibril formation in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Apolipoprotein E and antioxidants have different mechanisms of inhibiting Alzheimer's beta-amyloid fibril formation in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Inhibition of Alzheimer beta-fibrillogenesis by melatonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Nicotine inhibits amyloid formation by the beta-peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

The origins of Alzheimer disease: a is for amyloid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Does smoking protect from Alzheimer's disease? Alzheimer-type changes in 301 unselected brains from patients with known smoking history.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Nicotine modulates the neurotoxic effect of beta-amyloid protein(25-35)) in hippocampal cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

Nicotine and amyloid formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901417-8

10.1016/S0006-3223(02)01417-8

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference